A study of human epidermal growth factor receptor 2 overexpression by immunohistochemistry in patients with gastric adenocarcinoma

Gastric cancer is one of the leading causes of cancer-related deaths across the world and in the Middle East. Human epidermal growth factor receptor 2 (HER2) overexpression has been observed in gastric cancers. Trastuzumab, a recombinant monoclonal antibody targeting HER2 protein, is being used for...

Descripción completa

Detalles Bibliográficos
Autores principales: ABOOD, RAFID A., ALOMAR, SAAD, ALHAROON, SAWSAN S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583233/
https://www.ncbi.nlm.nih.gov/pubmed/37859935
http://dx.doi.org/10.4081/jphia.2023.2721

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583233/
https://www.ncbi.nlm.nih.gov/pubmed/37859935
http://dx.doi.org/10.4081/jphia.2023.2721

Ejemplares similares